The research library
Every primary source behind a claim on this site, tier-graded for provenance and tagged for the strength of the evidence it carries. 31 of 36 sources match the filters.
- Sources indexed
- 36
- Peptides covered
- 20
- Tier 1 share
- 100%
F·Filter
Reset all- Tier 1 · Peer primarystrongRCT
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. · 2023 · New England Journal of Medicine
- Tier 1 · Peer primarystrongRCT
Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Jastreboff AM, Kaplan LM, Frías JP, et al. · 2023 · New England Journal of Medicine
- Tier 1 · Peer primarystrongRCT
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial
Karaa A, Bertini E, Carelli V, et al. · 2023 · Neurology
- Tier 1 · Peer primarystrongRCT
Tirzepatide Once Weekly for the Treatment of Obesity
Jastreboff AM, Aronne LJ, Ahmad NN, et al. · 2022 · New England Journal of Medicine
- Tier 1 · Peer primarystrongRCT
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension
Wilding JPH, Batterham RL, Davies M, et al. · 2022 · Diabetes, Obesity and Metabolism
- Tier 1 · Peer primarystrongRCT
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding JPH, Batterham RL, Calanna S, et al. · 2021 · New England Journal of Medicine
- Tier 1 · Peer primarystrongRCT
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
Frías JP, Davies MJ, Rosenstock J, et al. · 2021 · New England Journal of Medicine
- Tier 1 · Peer primarystrongRCT
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial
Rubino D, Abrahamsson N, Davies M, et al. · 2021 · JAMA
- Tier 1 · Peer primarystrongRCT
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
Kingsberg SA, Clayton AH, Portman D, et al. · 2019 · Obstetrics and Gynecology
- Tier 1 · Peer primarymoderateMechanistic
GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells
Filatova E, Kasian A, Kolomin T, et al. · 2017 · Frontiers in Pharmacology
- Tier 1 · Peer primarystrongRCT
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso SP, Bain SC, Consoli A, et al. · 2016 · New England Journal of Medicine
- Tier 1 · Peer primarystrongMechanistic
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
Lau J, Bloch P, Schäffer L, et al. · 2015 · Journal of Medicinal Chemistry
- Tier 1 · Peer primarymoderateRCT
Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial
Sosne G, Dunn SP, Kim C · 2015 · Cornea
- Tier 1 · Peer primarystrongMechanistic
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
Lee C, Zeng J, Drew BG, et al. · 2015 · Cell Metabolism
- Tier 1 · Peer primarymoderateMechanistic
Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents
McCoy AT, Benoist CC, Wright JW, et al. · 2013 · Journal of Pharmacology and Experimental Therapeutics
- Tier 1 · Peer primarystrongMeta-analysis
Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data
Falutz J, Mamputu JC, Potvin D, et al. · 2010 · Journal of Clinical Endocrinology & Metabolism
- Tier 1 · Peer primarymoderateRCT
Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank in the therapy of generalized anxiety disorders and neurasthenia
Zozulia AA, Neznamov GG, Siuniakov TS, et al. · 2008 · Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
- Tier 1 · Peer primarymoderateMechanistic
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system
Klicek R, Sever M, Radic B, et al. · 2008 · Journal of Pharmacological Sciences
- Tier 1 · Peer primarystrongRCT
Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial
Nass R, Pezzoli SS, Oliveri MC, et al. · 2008 · Annals of Internal Medicine
- Tier 1 · Peer primarymoderateMechanistic
PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation
Dalmasso G, Charrier-Hisamuddin L, Nguyen HTT, et al. · 2008 · Gastroenterology
- Tier 1 · Peer primarymoderateMechanistic
Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analogue
Ferdinandi ES, Brazeau P, High K, et al. · 2007 · Basic and Clinical Pharmacology & Toxicology
- Tier 1 · Peer primarystrongRCT
Metabolic effects of a growth hormone-releasing factor in patients with HIV
Falutz J, Allas S, Blot K, et al. · 2007 · New England Journal of Medicine
- Tier 1 · Peer primarystrongRCT
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
Teichman SL, Neale A, Lawrence B, et al. · 2006 · Journal of Clinical Endocrinology & Metabolism
- Tier 1 · Peer primarymoderateMechanistic
Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon-to-bone healing and opposed corticosteroid aggravation
Krivic A, Anic T, Seiwerth S, et al. · 2006 · Journal of Orthopaedic Research
- Tier 1 · Peer primarymoderateMechanistic
Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents
Eremin KO, Kudrin VS, Saransaari P, et al. · 2005 · Neurochemical Research
- Tier 1 · Peer primarymoderateMechanistic
Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair
Bock-Marquette I, Saxena A, White MD, et al. · 2004 · Nature
- Tier 1 · Peer primarymoderateMechanistic
Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells
Khavinson VKh, Bondarev IE, Butyugov AA · 2003 · Bulletin of Experimental Biology and Medicine
- Tier 1 · Peer primarymoderateRCT
MK-677, an Orally Active Growth Hormone Secretagogue, Reverses Diet-Induced Catabolism
Murphy MG, Plunkett LM, Gertz BJ, et al. · 1998 · Journal of Clinical Endocrinology & Metabolism
- Tier 1 · Peer primarystrongMechanistic
Ipamorelin, the first selective growth hormone secretagogue
Raun K, Hansen BS, Johansen NL, et al. · 1998 · European Journal of Endocrinology
- Tier 1 · Peer primarymoderateRCT
A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody-- and hepatitis B virus DNA--positive chronic hepatitis B
Andreone P, Cursaro C, Gramenzi A, et al. · 1996 · Hepatology
- Tier 1 · Peer primarymoderateMechanistic
The delta EEG (sleep)-inducing peptide (DSIP). XI. Amino-acid analysis, sequence, synthesis and activity of the nonapeptide
Schoenenberger GA, Maier PF, Tobler HJ, et al. · 1978 · Pflügers Archiv